NPSP NPS Pharmaceutical | Stock Discussion Forums

Biotech / Medical: NPSP NPS Pharmaceutical

Posts: 348 | Member SubjectMarks: 46 | No Bans

SI Sentiment for NPSP: Insufficient votes accumulated

Add SubjectMark | Hide Original Post | Show Chart | Poster Summary | Share This Board

Moderated By: Jim Langdon -- (Not Moderated) -- Started: 8/5/1996 8:27:00 PM Revision History

Anyone follow this small biotech company. Its lead drug is Norcalcin for the treatment of HPT. Norcalcin is starting the second phase trials and mimicks the action of calcium by activating the calcium receptor. Recently Amgen has signed a 43.5 million dollar deal to develop and market the drug. Recently touted by George Southerland in his newsletter. Any comments apprriciated!

Previous 10 | Next 10 | View Recent | Post Message

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Date
348	>>NPS regains right to drugs from Takeda for $50 mln in NPS shares	tuck	-	03/19/2013 01:55 PM
347	Gattex approved, no CC until 1/2/2013, though. Wacky day, approval expected, so	tuck	-	12/21/2012 02:08 PM
346	AC panel unanimously backs Gattex, stock halted. Nice one Cramer. >>NPS	tuck	-	10/17/2012 01:23 AM
345	More Natpara data: >>NPS Pharmaceuticals, Inc. ( NPSP), a biopharmaceutic	tuck	-	10/15/2012 03:39 PM
344	AC meeting next Tuesday on Gattex. Briefing docs here: http:/// Cheers, Tuck	tuck	-	10/12/2012 10:22 AM
343	EU approved Revestive a month ago: >>OSAKA, Japan & BEDMINSTER, N.J.-	tuck	-	10/03/2012 11:04 AM
342	NPS sells post-2018 Sensipar royalties back to Amgen. >>NPS Pharmaceutica	tuck	-	07/02/2012 09:37 AM
341	Positive CHMP opinion for teduglutide, which now has the trade name Revestive in	tuck	-	06/22/2012 09:24 AM
340	Sounds like typical SA optimism, especially wrt a buyout. Nevertheless, holding	tuck	-	01/23/2012 06:13 PM
339	http://seekingalpha.com/article/321380-2-high-risk-high-reward-biotechs-that-cou	steve kammerer	-	01/23/2012 03:49 PM
338	[graphic] New Steps 2 data includes patient deaths. Bu	tuck	-	10/31/2011 12:50 PM

Go to reply# or date (mm/dd/yy):